"Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
| Descriptor ID |
D014612
|
| MeSH Number(s) |
D20.215.894
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Vaccines".
This graph shows the total number of publications written about "Vaccines" by people in this website by year, and whether "Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 5 | 5 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 2 | 3 |
| 1999 | 2 | 1 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 2 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 5 | 7 | 12 |
| 2006 | 4 | 1 | 5 |
| 2007 | 1 | 1 | 2 |
| 2008 | 6 | 2 | 8 |
| 2009 | 1 | 2 | 3 |
| 2010 | 7 | 0 | 7 |
| 2011 | 9 | 1 | 10 |
| 2012 | 4 | 1 | 5 |
| 2013 | 13 | 3 | 16 |
| 2014 | 14 | 4 | 18 |
| 2015 | 8 | 1 | 9 |
| 2016 | 15 | 1 | 16 |
| 2017 | 11 | 3 | 14 |
| 2018 | 6 | 3 | 9 |
| 2019 | 13 | 6 | 19 |
| 2020 | 14 | 4 | 18 |
| 2021 | 15 | 1 | 16 |
| 2022 | 20 | 1 | 21 |
| 2023 | 20 | 1 | 21 |
| 2024 | 12 | 2 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines" by people in Profiles.
-
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 2024 Sep; 133(3):286-294.
-
The zebrafish as a potential model for vaccine and adjuvant development. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):535-545.
-
Vaccines as Immunotherapies for Substance Use Disorders. Am J Psychiatry. 2024 May 01; 181(5):362-371.
-
Frequency of vaccine hesitancy among patients with advanced cancer. Palliat Support Care. 2024 Apr; 22(2):289-295.
-
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial. Lancet Infect Dis. 2024 Jul; 24(7):760-774.
-
Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association. J Med Virol. 2024 Mar; 96(3):e29505.
-
Neighborhood-level disadvantages increase risk for invasive pneumococcal disease. Am J Med Sci. 2024 05; 367(5):304-309.
-
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study. Vaccine. 2024 Mar 07; 42(7):1512-1520.
-
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021 Emerg Infect Dis. 2024 02; 30(2):245-254.
-
Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2024 Mar 07; 42(7):1799-1811.